mexiletine hydrochloride 150 mg

INDICATIONS AND USAGE Mexiletine hydrochloride capsules are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. Because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided. Initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. Antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias.

Camber Pharmaceuticals, Inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] pain` `[4] nausea` `[5] off label use` `[6] headache` `[7] dyspnoea` `[8] diarrhoea` `[9] arthralgia` `[10] vomiting`

10 months ago

CAPSULE BLUE V1 30

HOW SUPPLIED

MEXILETINE HYDROCHLORIDE capsules USP, 150 mg are white opaque/light blue opaque colored size '2', hard gelatin capsules, imprinted with “V1” on cap and “30” on body, filled with white to off white granular powder. They are supplied as follows: Bottles of 100 NDC 31722-036-01

MEXILETINE HYDROCHLORIDE capsules USP, 200 mg are white opaque/light blue opaque colored size '1', hard gelatin capsules, imprinted with “V1” on cap and “33” on body, filled with white to off white granular powder. They are supplied as follows: Bottles of 100 NDC 31722-037-01

MEXILETINE HYDROCHLORIDE capsules USP, 250 mg are white opaque/light blue opaque colored size '0', hard gelatin capsules, imprinted with “V1” on cap and “34” on body, filled with white to off white granular powder. They are supplied as follows: Bottles of 100 NDC 31722-038-01 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). For more information, call Annora Pharma Private Limited at 1-866-495-1995. Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 Manufactured by: Annora Pharma Private Limited Sy. No. 261, Annaram Village, Gummadidala Mandal, Sangareddy District-502313 Telangana, India. Revised: 11/2022 mexiletine-hcl-caps-camber-logo

More pills like CAPSULE V1 30

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

mexiletine hydrochloride 150 mg

FDA Reported Adverse Reactions [1] fatigue [2] drug ineffective [3] pain [4] nausea [5] off label use [6] headache [7] dyspnoea [8] diarrhoea [9] arthralgia [10] vomiting

CAPSULE BLUE V1 30

More pills like CAPSULE V1 30

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] pain` `[4] nausea` `[5] off label use` `[6] headache` `[7] dyspnoea` `[8] diarrhoea` `[9] arthralgia` `[10] vomiting`